CytomX Therapeutics (CTMX) Asset Utilization Ratio (2015 - 2026)
CytomX Therapeutics' (CTMX) Asset Utilization Ratio was 0.05 for Q2 2026, down 95.2% from 1.03 a year earlier and down 64.5% from the prior quarter.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
For FY2025, Asset Utilization Ratio at CytomX Therapeutics was 0.56, down 34.6% from FY2024.
- By year, Asset Utilization Ratio came in at 0.86 in FY2024 (+95.9%), 0.44 in FY2023 (+147.0%), 0.18 in FY2022 (+65.7%) and 0.11 in FY2021 (-45.3%).
- The Q2 2026 figure ranks as the lowest quarterly Asset Utilization Ratio since Q2 2016.
- Year over year, Asset Utilization Ratio has now declined in each of the last four quarters, with growth averaging 15.5% over the last eight quarters.
- The high point for year-over-year Asset Utilization Ratio in five years was Q3 2023 (growth of 142.5%); the low point was Q2 2026 (a decline of 95.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 0.14 (Q1 2026), 0.49 (Q4 2025) and 0.68 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 0.47 |
| 10 | CytomX Therapeutics | 586.15 Mn | -371.52 Mn | - | 0.05 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.05 |
| Mar 31, 2026 | 0.14 |
| Dec 31, 2025 | 0.49 |
| Sep 30, 2025 | 0.68 |
| Jun 30, 2025 | 1.03 |
| Mar 31, 2025 | 1.35 |
| Dec 31, 2024 | 1.06 |
| Sep 30, 2024 | 0.85 |
| Jun 30, 2024 | 0.70 |
| Mar 31, 2024 | 0.62 |
| Dec 31, 2023 | 0.48 |
| Sep 30, 2023 | 0.44 |
| Jun 30, 2023 | 0.36 |
| Mar 31, 2023 | 0.27 |
| Dec 31, 2022 | 0.22 |
| Sep 30, 2022 | 0.18 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.12 |
| Dec 31, 2021 | 0.11 |
| Sep 30, 2021 | 0.09 |
API Access
CytomX Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();